Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine ...

BioNTech has agreed to acquire biotechnology company Biotheus for $800 million up front and up to $150 million in milestone payments. The German developer of RNA vaccines and immunotherapies said ...

Vaccines that prevent smallpox and mpox come in two varieties. One uses a single shot of a live virus but carries the risk of ...

BioNTech is buying into one of the hottest areas of oncology, agreeing to pay $800 million to acquire China-based Biotheus ...

U.S. FDA removes clinical hold on Investigational New Drug application for COVID-19-Influenza Combination and stand-alone influenza vaccine candidates Achieved total ...

German drugmaker BioNTech on Monday lowered its guidance for full-year revenue, citing COVID-19 uptake and price levels, inventory write-downs and Pfizer charges.

Kenya has recorded nearly four million cases of Malaria this year, latest data from the Ministry of Health shows.

Malaria is as old as the Egyptian civilization, and the fight against it spans nearly 100 years in Egypt. Egypt recently achieved a monumental feat by receiving WHO certification for eliminating ...

N’Djamena — Chad today kicked off an ambitious triple vaccine rollout, including the R21 malaria vaccine, marking a significant step forward in its efforts to safeguard the health and well ...

Dr. Anthony Fauci spoke at a rare briefing from the White House virus task force to reassure some public concerns about the two vaccines - one from Pfizer/BioNTech and the other by Moderna - after ...

On Aug. 22, the Food and Drug Administration approved and authorized newer formulations of the two mRNA vaccines, from Pfizer/BioNTech and Moderna, for ages 6 months and up. About a week later ...